The Role of 18^F-FDG PET/CT in the Evaluation of Gastric Cancer Recurrence after Curative Gastrectomy
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: 18^F-fluorodeoxyglucose positron emission tomography/computed tomography (18^F-FDG PET/CT) scans are frequently performed for the screening or staging of malignant tumors. This study aimed to assess the usefulness of 18^F-FDG PET/CT in detection of gastric cancer recurrence after curative gastrectomy. Materials and Methods: Eighty nine patients who had undergone curative gastrectomy due to gastric cancer and had 18^F-FDG PET/CT and contrast CT scans within 2 weeks for surveillance in asymptomatic patients (n = 11) or to clarify suspected recurrence (n = 78) were consecutively collected and retrospectively analyzed. They had clinical follow-up for at least 12 months after PET/CT and CT scans. Results: Fifteen of the 89 patients (16.9%) were diagnosed with recurrent gastric cancer in 21 organs. Forty one organs showed an increase in FDG uptake, and only 9 of these organs were diagnosed with recurrent gastric cancer by 18^F-FDG PET/CT. The sensitivity,specificity, positive predictive value, negative predictive value, and diagnostic accuracy of the 18F-FDG PET/CT were 42.9%, 59.7%, 29.3%, 78.2%, and 57.3%, respectively. On the CT scan, 18 of 21 recurrent gastric cancers were detected,and 7 cases were in agreement with the 18^F-FDG PET/CT. The sensitivity and specificity of the CT scan were 85.8% and 87.3%, respectively, which are superior to the 18^F-FDG PET/CT. When we diagnosed a recurrence based on either 18^F-FDG PET/CT or CT scans, the sensitivity increased to 95.2% and the specificity decreased to 45.6%, when compared with the contrast CT scan alone. Conclusion: 18^F-FDG PET/CT is an insufficient diagnostic method in detection of recurrence after curative gastrectomy, and even less accurate than contrast CT scan alone.
Abstract
Purpose: 18^F-fluorodeoxyglucose positron emission tomography/computed tomography (18^F-FDG PET/CT) scans are frequently performed for the screening or staging of malignant tumors. This study aimed to assess the usefulness of 18^F-FDG PET/CT in detection of gastric cancer recurrence after curative gastrectomy. Materials and Methods: Eighty nine patients who had undergone curative gastrectomy due to gastric cancer and had 18^F-FDG PET/CT and contrast CT scans within 2 weeks for surveillance in asymptomatic patients (n = 11) or to clarify suspected recurrence (n = 78) were consecutively collected and retrospectively analyzed. They had clinical follow-up for at least 12 months after PET/CT and CT scans. Results: Fifteen of the 89 patients (16.9%) were diagnosed with recurrent gastric cancer in 21 organs. Forty one organs showed an increase in FDG uptake, and only 9 of these organs were diagnosed with recurrent gastric cancer by 18^F-FDG PET/CT. The sensitivity,specificity, positive predictive value, negative predictive value, and diagnostic accuracy of the 18F-FDG PET/CT were 42.9%, 59.7%, 29.3%, 78.2%, and 57.3%, respectively. On the CT scan, 18 of 21 recurrent gastric cancers were detected,and 7 cases were in agreement with the 18^F-FDG PET/CT. The sensitivity and specificity of the CT scan were 85.8% and 87.3%, respectively, which are superior to the 18^F-FDG PET/CT. When we diagnosed a recurrence based on either 18^F-FDG PET/CT or CT scans, the sensitivity increased to 95.2% and the specificity decreased to 45.6%, when compared with the contrast CT scan alone. Conclusion: 18^F-FDG PET/CT is an insufficient diagnostic method in detection of recurrence after curative gastrectomy, and even less accurate than contrast CT scan alone.
참고문헌 (17)
- Schwarz RE, "Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy", Ann Surg Oncol, 9, pp.394~400 (2002)
- Yoo CH, "Recurrence following curative resection for gastric carcinoma", Br J Surg, 87, pp.236~242 (2000)
- Lim JS, "CT and PET in stomach cancer: Preoperative staging and monitoring of response to therapy", RADIOGRAPHICS, 26, pp.143~156 (2006)
- Habermann CR, "Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US", Radiology, 230, pp.465~471 (2004)
- Kuntz C, "Imaging diagnosis for staging of gastric cancer", Semin Surg Oncol, 17, pp.96~102 (1999)
- Halvorsen RA Jr, "Diagnosis and staging of gastric cancer", Semin Oncol, 23, pp.325~335 (1996)
- Park MJ, "Detecting recurrence of gastric cancer: the value of FDG PET", CT, 2009, pp.34, 441~447
- Sun L, "Clinical role of 18F-fluorodeoxyglucose positron emission tomography", computed tomography in post-operative follow up of gastric cancer: initial results, 2008, pp.14, 4627~4632
- Sim SH, "The role of PET", CT in detection of gastric cancer recurrence, 2009, pp.9(73), 1~7
- De Potter T, "Whole-body PET with FDG for the diagnosis of recurrent gastric cancer", Eur J Nucl Med Mol Imaging, 29, pp.525~529 (2002)
- Nakamoto Y, "Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study", Jpn J Clin Oncol, 39, pp.297~302 (2009)
- Sobin LH, "TNM classification of malignant tumors. 6th ed. International union against cancer (UICC)" (2002), Wilwy-Liss
- 윤미진, "악성 소화기 종양에서 F-18 FDG PET 또는 PET", CT 검사의 의의, 2006, pp.48(6), 378~387[DOI]
- Yun M, "The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET", J Nucl Med, 46, pp.953~957 (2005)
- Nunez RF, "Macapinlac H. Increased F-18 FDG uptake in the stomach", Clin Nucl Med, 24, pp.281~282 (1999)
- Beatty JS, "Incidental PET", CT findings in the cancer patient: how should they be managed, 2009, pp.146, 274~281
- Ishimori T, "Detection of unexpected additional primary malignancies with PET", CT, 2005, pp.46, 752~757